Liven Pharmaceuticals just made a rights issue. Will this prove to be the last throw of the dice?

The pharmaceutical company has had a torrid history. The new development could prove to be its redemption

For many, the name Liven Pharmaceuticals will be new. The company came into existence less than a decade ago and has only recently been listed on the stock exchange. Liven was established by a group of sponsors who wanted to create a pharmaceutical company providing health and medication solutions. The company name “Liven” was a play on the word living. 

But Liven’s roots can be traced farther back. The company’s origin story goes all the way back to the early 1990s when a company called Merchant’s Glass began manufacturing medical ampoules which are used to package certain medication and medical products. 

Liven was going to be the next stage of evolution for the company as it was going to address the patient needs by producing high quality medicines, biologicals and Active Pharmaceutical Ingredients (APIs).

 

To read the full article, subscribe and support independent business journalism in Pakistan

The content in this publication is expensive to produce. But unlike other journalistic outfits, business publications have to cover the very organizations that directly give them advertisements. Hence, this large source of revenue, which is the lifeblood of other media houses, is severely compromised on account of Profit’s no-compromise policy when it comes to our reporting. No wonder, Profit has lost multiple ad deals, worth tens of millions of rupees, due to stories that held big businesses to account.

Hence, for our work to continue unfettered, it must be supported by discerning readers who know the value of quality business journalism, not just for the economy but for the society as a whole.

(Already a subscriber? Click here to login)
  • Full Price Subscription Plans

    Not only will you be supporting independent journalism, 25% of the amount from your subscription will be used to subsidise those subscribers who cannot afford the full price of the subscription. As a subscriber you will get full access to exclusive paywalled content, and an ad free reading experience. Yearly full price subscription plans also include a complimentary annual subscription to The Wall Street Journal.

    +

  • Subsidised Subscription Plans

    Pay part of the full subscription price, if you cannot afford to pay all of it, and the rest will be subsidised by a full paying subscriber. As a subscriber you will get access to exclusive paywalled content, and an ad free reading experience.

  • Free Student Subscriptions

    If you are currently a student, you can claim an already-paid-for digital subscription, courtesy

    As a subscriber you will get access to exclusive paywalled content, an ad free reading experience.

     

Zain Naeem
Zain Naeem
Zain is a business journalist at Profit, and can be reached at [email protected]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Posts